Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Wilms Tumor × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wilms Tumor 1 Neuroblastoma 1 Neoplasms 1 Kidney Neoplasms 1 Ganglioneuroblastoma 1

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 fludarabine 2 X-Rays 2 Vincristine 2 Temozolomide 2 Specimen Handling 2 Phantoms, Imaging 2 Irinotecan 2 Etoposide 2 talazoparib 1 selinexor 1 irinotecan sucrosofate 1 cabozantinib 1 Topotecan 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Isotretinoin 1 Ifosfamide 1 Doxorubicin 1 Data Collection 1 Carboplatin 1 Bone Density 1 Blood Specimen Collection 1 Biopsy 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡